๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong flag Hong Kong ยท Delayed Price ยท Currency is HKD
0.1160
-0.0080 (-6.45%)
Nov 20, 2026, 3:28 PM HKT

HKG:8329 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
912.25972.011,0421,065986.69838.81
Revenue Growth
-6.15%-6.69%-2.17%7.92%17.63%-18.67%
Gross Profit
263.65287.22328.04439.24443.68368.13
Operating Income
8.8320.5734.7848.1885.4235.75
Net Income
-52.76-40.7425.0124.1354.3535.96
Earnings Per Share
-0.03-0.020.010.010.030.02
EPS Growth
--3.68%-55.61%51.14%-1.73%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing and Selling of Medicines and Medical Devices
510.65551.5576.48611.48724.77547.8
Sales and Distribution of Medicines and Healthcare Products and Medical Devices
464.42490523.05554.63326.96337.32
Elimination of Inter-Segment
-62.82-69.49-57.83-101.25-65.05-46.31
Total
912.25972.011,0421,065986.69838.81

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
212.26209.36283.42382.21350.1311.14
Total Debt
96.3972.99105.4389.6992.69105.69
Net Cash (Debt)
115.87136.37177.99292.52257.41205.45
Net Cash Growth
-15.03%-23.39%-39.15%13.64%25.29%-49.38%
Net Cash Per Share
0.070.080.110.170.150.12

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
98.43139.5924.4153.6961.22-69.92
Capital Expenditures
-8.02-11.3-19.13-15.21-19.69-11.72
Free Cash Flow
90.41128.295.2838.4741.53-81.64
Free Cash Flow Growth
-29.53%2328.39%-86.27%-7.35%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
28.90%29.55%31.49%41.25%44.97%43.89%
Operating Margin
0.97%2.12%3.34%4.52%8.66%4.26%
Pretax Margin
-6.73%-5.00%2.85%2.88%8.34%4.66%
Profit Margin
-5.78%-4.19%2.40%2.27%5.51%4.29%
FCF Margin
9.91%13.20%0.51%3.61%4.21%-9.73%

Dividends

Fiscal Year
CurrentFY 2025FY 2024
Period EndingNov '26 Dec '25 Dec '24
Dividend Per Share
0.047-0.005
Dividend Per Share Growth
0%--
Dividend Yield
40.59%-3.26%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--10.2810.354.707.03
P/FCF Ratio
1.861.8748.656.496.15-
PS Ratio
0.180.250.250.240.260.30